Myriad

10 Best Nasdaq Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:49 pm
Incyte
Myriad
Cara Therapeutics
Sucampo
ZS Pharma
Concert Pharmaceuticals
The Medicines Company
Lexicon Pharmaceuticals
Exelixis
Anacor
Gene Patents Limited by Court in Mixed Ruling for Myriad
Bloomberg
Thu, 06/13/13 - 12:05 pm
Myriad
patents
gene patents
Supreme Court
Crescendo raises $56M, enters pact with Myriad
Mon, 09/12/11 - 10:53 pm
Crescendo
fundraising
Myriad
Myriad Beats by a Penny
Yahoo/Zacks.com
Thu, 11/4/10 - 11:47 am
Myriad
earnings
Myriad joins Abbott Labs' breast cancer study
Yahoo/AP
Wed, 10/27/10 - 11:41 am
Myriad
Abbott Laboratories
breast cancer
GlaxoSmithKline, J&J and Myriad lead drug stocks lower
Marketwatch
Fri, 07/9/10 - 11:22 am
GSK
Myriad
drug stocks
JNJ
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Wed, 07/7/10 - 09:36 am
Vivus
Qnexa
Myriad
Genomic Health
NicOx
naproxcinod
Savient
Krystexxa
Novartis
Gilenia
Seattle Genetics
Gilead Sciences
Chelsea Therapeutics
Eisai
Myriad Pharmaceuticals: A Value Investor's Dream
Seeking Alpha
Mon, 06/21/10 - 09:39 am
Myriad
Myriad Pharma plans job cuts and ends HIV program
Yahoo/AP
Wed, 06/9/10 - 07:37 am
HIV
Myriad
Myrexis
layoffs
Hospira-Javelin Merger in Trouble
Yahoo/Zacks.com
Fri, 06/4/10 - 12:59 pm
Hospira
Javelin
M&A
Myriad
Javelin Pharmaceuticals ends deal with Myriad
Yahoo/AP
Mon, 04/19/10 - 11:10 am
Javelin
Myriad
partnerships
Hospira offers competing bid to buy Javelin Pharma
Yahoo/AP
Mon, 04/12/10 - 12:02 pm
Hospira
Javelin
M&A
Myriad
Javelin rockets, Myriad gains on merger termination
Marketwatch
Mon, 04/12/10 - 10:47 am
Javelin
Myriad
Hospira
Myriad Fallout: Who Are the Winners and Losers in the Gene Patent Ruling?
BNET Pharma
Fri, 04/2/10 - 09:05 am
Myriad
genes
patents
Myriad falls on patent ruling; drug indices slip
Marketwatch
Tue, 03/30/10 - 11:14 am
Myriad
patents
drug stocks
Experts predict biotech doom with loss of gene patents
Fierce Biotech
Fri, 02/5/10 - 10:50 am
generics
Myriad
patents
Partnering Activity Skyrockets as Biotechs Close Year-End Deals
BNET Pharma
Wed, 12/23/09 - 08:42 am
biotech
* Incyte
Eli Lilly
OncoGenex
Teva Pharmaceuticals
Biovitrum
Eisai
AkaRx
Thallion Pharmaceuticals
LFB Biotechnologies
Athersys
Pfizer
Myriad
Javelin
Durata Therapeutics
Vicuron
Javelin to merge with Myriad Pharma
bizjournals.com
Sat, 12/19/09 - 12:31 pm
Javelin
Myriad
Myriad Pharmaceuticals' Azixa(TM) is Efficacious in a Model of Human Brain Cancer and Its Activity is Additive With Avastin(R)
Yahoo/Global News Wire
Sat, 10/24/09 - 10:47 am
Myriad
Azixa
Avastin
brain cancer
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
Seeking Alpha
Wed, 05/27/09 - 07:41 am
Gilead Sciences
Amgen
Human Genome Sciences
Acorda Therapeutics
Biomarin
Amag Pharmaceuticals
Biogen Idec
Genzyme
Cougar Biotechnology
JNJ
OSI Pharmaceuticals
Cephalon
Allergan
Celgene
Myriad
Sequenom
Auxilium